Answers are grounded in this paper and cite their sources.
HIV-1 RNA level and darunavir concentration in the genital tract were measured in 45 men receiving darunavir-ritonavir mono- or tritherapy. At week 48, a low frequency (3/45) of HIV-1 RNA shedding was observed in patients (1 on monotherapy and 2 on triple therapy), although they had undetectable HIV-1 RNA in plasma. The median darunavir seminal plasma concentration was close to the blood plasma free fraction, demonstrating a good penetration of darunavir into the male genital tract.
No takes yet. Share an insight, caveat, or question.
Lambert-Niclot et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: